NCT04661280View on ClinicalTrials.gov

Donepezil Versus Non-drug Treatment in Alzheimer's Disease.

PHASE3RecruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

February 10, 2022

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Alzheimer Disease, Early Onset
Interventions
DRUG

Donepezil

Donepezil 5 mg per day during one month, then 10 mg per day during 5 months.

Trial Locations (1)

75010

RECRUITING

Cognitive Neurology Center, Paris

All Listed Sponsors
collaborator

France Alzheimer

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER